...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

I bought some of these and they sit in my fidelity account.  Recently trading has picked up, with some days reaching 100k.  Fidelity would not hold scam shares, imo.  its trading on the pinks, not the grays. 

Share
New Message
Please login to post a reply